|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nawrot TS, Martens DS, Hara A, Plusquin M,
Vangronsveld J, Roels HA and Staessen JA: Association of total
cancer and lung cancer with environmental exposure to cadmium: The
meta-analytical evidence. Cancer Causes Control. 26:1281–1288.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verma M: Environmental and occupational
risk factors for lung cancer, methods of molecular biology. Cancer
Epidemiol. 472:3–23. 2009. View Article : Google Scholar
|
|
4
|
Garcia-Esquinas E, Pollan M, Tellez-Plaza
M, Francesconi KA, Goessler W, Guallar E, Umans JG, Yeh J, Best LG
and Navas-Acien A: Cadmium exposure and cancer mortality in a
prospective cohort: The strong heart study. Environ Health
Perspect. 122:363–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stayner L, Smith R, Thun M, Schnorr T and
Lemen R: A dose-response analysis and quantitative assessment of
lung cancer risk and occupational cadmium exposure. Ann Epidemiol.
2:177–194. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meeting of the IARC working group on
beryllium, cadmium, mercury and exposures in the glass
manufacturing industry. Scand J Work Environ Health. 19:360–363.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Person RJ, Tokar EJ, Xu Y, Orihuela R,
Ngalame NN and Waalkes MP: Chronic cadmium exposure in vitro
induces cancer cell characteristics in human lung cells. Toxicol
Appl Pharmacol. 273:281–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huff J, Lunn RM, Waalkes MP, Tomatis L and
Infante PF: Cadmium-induced cancers in animals and in humans. Int J
Occup Environ Health. 13:202–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luevano J and Damodaran C: A review of
molecular events of cadmium-induced carcinogenesis. J Environ
Pathol Toxicol Oncol. 33:183–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo H, Li Z, Ge H, Mei D, Zhao L, Jiang L,
Geng C, Li Q, Yao X and Cao J: HMGA2 upregulation mediates
Cd-induced migration and invasion in A549 cells and in lung tissues
of mice. Chem Biol Interact. 277:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv W, Sui L, Yan X, Xie H, Jiang L, Geng
C, Li Q, Yao X, Kong Y and Cao J: ROS-dependent Atg4 upregulation
mediated autophagy plays an important role in Cd-induced
proliferation and invasion in A549 cells. Chem Biol Interact.
279:136–144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu P, Liao LY, Zhao TT, Mo XM, Chen GG
and Liu ZM: GPER/ERK&AKT/NF-κB pathway is involved in
cadmium-induced proliferation, invasion and migration of
GPER-positive thyroid cancer cells. Mol Cell Endocrinol. 442:68–80.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei Y, Zhao L, He W, Yang J, Geng C, Chen
Y, Liu T, Chen H and Li Y: Benzo[a]pyrene promotes gastric cancer
cell proliferation and metastasis likely through the Aryl
hydrocarbon receptor and ERK-dependent induction of MMP9 and c-myc.
Int J Oncol. 49:2055–2063. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Pan T, Li L, Wang H, Zhang D and
Yang H: Benzo(a)pyrene promotes Hep-G2 cell migration and invasion
by upregulating phosphorylated extracellular signal-regulated
kinase expression. Oncol Lett. 15:8325–8332. 2018.PubMed/NCBI
|
|
15
|
Sharma K, Singh J, Frost EE and Pillai PP:
MeCP2 overexpression inhibits proliferation, migration and invasion
of C6 glioma by modulating ERK signaling and gene expression.
Neurosci Lett. 674:42–48. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Y, Lan M, Chen X, Dai Y, Zhao X, Wang
L, Zhao T, Li Y, Zhu J, Zhang X, et al: Anti-invasion and
anti-metastasis effects of Valjatrate E via reduction of matrix
metalloproteinases expression and suppression of MAPK/ERK signaling
pathway. Biomed Pharmacother. 104:817–824. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Quintero Barceinas RS, Garcia-Regalado A,
Arechaga- Ocampo E, Villegas-Sepulveda N and Gonzalez-De la Rosa
CH: All-Trans retinoic acid induces proliferation, survival, and
migration in A549 lung cancer cells by activating the ERK signaling
pathway through a transcription-independent mechanism. Biomed Res
Int. 2015:4043682015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li G, He Y, Yao J, Huang C, Song X, Deng
Y, Xie S, Ren J, Jin M and Liu H: Angelicin inhibits human lung
carcinoma A549 cell growth and migration through regulating JNK and
ERK pathways. Oncol Rep. 36:3504–3512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang F, Tang S, Guo X, Yang C and Jia K:
CT45A1 siRNA silencing suppresses the proliferation, metastasis and
invasion of lung cancer cells by downregulating the ERK/CREB
signaling pathway. Mol Med Rep. 16:6708–6714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Zhang Y, Miao Y, Zhou H, Jiang G
and Wang E: TMEM17 depresses invasion and metastasis in lung cancer
cells via ERK signaling pathway. Oncotarget. 8:70685–70694.
2017.PubMed/NCBI
|
|
21
|
Yang J, Kuang XR, Lv PT and Yan XX:
Thymoquinone inhibits proliferation and invasion of human
nonsmall-cell lung cancer cells via ERK pathway. Tumour Biol.
36:259–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao YC, Shih YW, Chao CH, Lee XY and
Chiang TA: Involvement of the ERK signaling pathway in fisetin
reduces invasion and migration in the human lung cancer cell line
A549. J Agric Food Chem. 57:8933–8941. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shih YW, Wu PF, Lee YC, Shi MD and Chiang
TA: Myricetin suppresses invasion and migration of human lung
adenocarcinoma A549 cells: Possible mediation by blocking the ERK
signaling pathway. J Agric Food Chem. 57:3490–3499. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim JH, Cho EB, Lee J, Jung O, Ryu BJ, Kim
SH, Cho JY, Ryou C and Lee SY: Emetine inhibits migration and
invasion of human non-small-cell lung cancer cells via regulation
of ERK and p38 signaling pathways. Chem Biol Interact. 242:25–33.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Wang H, Pan T, Li L, Li J and Yang
H: STIM1 silencing inhibits the migration and invasion of A549
cells. Mol Med Rep. 16:3283–3289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu X, Price-Schiavi SA and Carraway KL:
Extracellular regulated kinase (ERK)-dependent regulation of
sialomucin complex/rat Muc4 in mammary epithelial cells. Oncogene.
19:4354–4361. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Martindale JL and Holbrook NJ:
Requirement for ERK activation in cisplatin-induced apoptosis. J
Biol Chem. 275:39435–39443. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Silvany RE, Eliazer S, Wolff NC and Ilaria
RL Jr: Interference with the constitutive activation of ERK1 and
ERK2 impairs EWS/FLI-1-dependent transformation. Oncogene.
19:4523–4530. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Raja R, Lata S, Trivedi S and Banerjea AC:
Serum deprivation/starvation leads to reactivation of HIV-1 in
latently infected monocytes via activating ERK/JNK pathway. Sci
Rep. 8:144962018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He Y, Peng L, Huang Y, Liu C, Zheng S and
Wu K: Blood cadmium levels associated with short distant
metastasis-free survival time in invasive breast cancer. Environ
Sci Pollut Res Int. 24:28055–28064. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Demir N, Enon S, Turksoy VA, Kayaalti Z,
Kaya S, Cangir AK, Soylemezoglu T and Savas I: Association of
cadmium but not arsenic levels in lung cancer tumor tissue with
smoking, histopathological type and stage. Asian Pac J Cancer Prev.
15:2965–2970. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Son YO, Wang L, Poyil P, Budhraja A,
Hitron JA, Zhang Z, Lee JC and Shi X: Cadmium induces
carcinogenesis in BEAS-2B cells through ROS-dependent activation of
PI3K/AKT/GSK-3β/β- catenin signaling. Toxicol Appl Pharmacol.
264:153–160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei Z and Shaikh ZA: Cadmium stimulates
metastasis-associated phenotype in triple-negative breast cancer
cells through integrin and β-catenin signaling. Toxicol Appl
Pharmacol. 328:70–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fujiki K, Inamura H, Miyayama T and
Matsuoka M: Involvement of Notch1 signaling in malignant
progression of A549 cells subjected to prolonged cadmium exposure.
J Biol Chem. 292:7942–7953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eblen ST: Extracellular-regulated kinases:
Signaling from ras to ERK substrates to control biological
outcomes. Adv Cancer Res. 138:99–142. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tanimura S and Takeda K: ERK signalling as
a regulator of cell motility. J Biochem. 162:145–154. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng X, Wang Z, Liu Y, Peng X, Liu Y, Zhu
S, Zhang Z, Qiu Y, Jin M, Wang R, et al: Oxyfadichalcone C inhibits
melanoma A375 cell proliferation and metastasis via suppressing
PI3K/Akt and MAPK/ERK pathways. Life Sci. 206:35–44. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Wang H, Sun K, Wang X, Pan H, Zhu
J, Ji X and Li X: Chrysin suppresses proliferation, migration, and
invasion in glioblastoma cell lines via mediating the ERK/Nrf2
signaling pathway. Drug Des Devel Ther. 12:721–733. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hong L, Wang Y, Chen W and Yang S:
MicroRNA-508 suppresses epithelial-mesenchymal transition,
migration, and invasion of ovarian cancer cells through the
MAPK1/ERK signaling pathway. J Cell Biochem. 119:7431–7440. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Chen H, She P, Chen T, Chen L, Yuan
J and Jiang B: microRNA-23a promotes cell growth and metastasis in
gastric cancer via targeting SPRY2-mediated ERK signaling. Oncol
Lett. 15:8433–8441. 2018.PubMed/NCBI
|
|
43
|
Dong QZ, Wang Y, Tang ZP, Fu L, Li QC,
Wang ED and Wang EH: Derlin-1 is overexpressed in non-small cell
lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated
up-regulation of MMP-2 and MMP-9. Am J Pathol. 182:954–964. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu Z, Wang T, Fang M, Huang W, Sun Z, Xiao
J and Yan W: MFAP5 promotes tumor progression and bone metastasis
by regulating ERK/MMP signaling pathways in breast cancer. Biochem
Biophys Res Commun. 498:495–501. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li X, Bao C, Ma Z, Xu B, Liu X, Ying X and
Zhang X: Perfluorooctanoic acid stimulates ovarian cancer cell
migration, invasion via ERK/NF-κB/MMP-2/-9 pathway. Toxicol Lett.
294:44–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu CC, Chen CA, Fu SL, Lin HY, Lee MS,
Chiou WY, Su YC and Hung SK: Andrographolide enhances the
anti-metastatic effect of radiation in Ras-transformed cells via
suppression of ERK-mediated MMP-2 activity. PLoS One.
13:e02056662018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang SL, Kuo FH, Chen PN, Hsieh YH, Yu NY,
Yang WE, Hsieh MJ and Yang SF: Andrographolide suppresses the
migratory ability of human glioblastoma multiforme cells by
targeting ERK1/2-mediated matrix metalloproteinase-2 expression.
Oncotarget. 8:105860–105872. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Favata MF, Horiuchi KY, Manos EJ, Daulerio
AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F,
et al: Identification of a novel inhibitor of mitogen-activated
protein kinase kinase. J Biol Chem. 273:18623–18632. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gao H, Zhang Y, Dong L, Qu XY, Tao LN,
Zhang YM, Zhai JH and Song YQ: Triptolide induces autophagy and
apoptosis through ERK activation in human breast cancer MCF-7
cells. Exp Ther Med. 15:3413–3419. 2018.PubMed/NCBI
|
|
50
|
Jiang X and Li H: Overexpression of LRIG1
regulates PTEN via MAPK/MEK signaling pathway in esophageal
squamous cell carcinoma. Exp Ther Med. 12:2045–2052. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang Y and Gong L: Palmitoleate inhibits
insulin transcription by activating the ERK1/2 pathway in rat
pancreatic beta-cells. Exp Ther Med. 13:2805–2811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Morishita A, Zaidi MR, Mitoro A,
Sankarasharma D, Szabolcs M, Okada Y, D'Armiento J and Chada K:
HMGA2 is a driver of tumor metastasis. Cancer Res. 73:4289–4299.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gao X, Dai M, Li Q, Wang Z, Lu Y and Song
Z: HMGA2 regulates lung cancer proliferation and metastasis.
Thoracic Cancer. 8:501–510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dong J, Wang R, Ren G, Li X, Wang J, Sun
Y, Liang J, Nie Y, Wu K, Feng B, et al: HMGA2-FOXL2 axis regulates
metastases and epithelial-to-mesenchymal transition of
chemoresistant gastric cancer. Clin Cancer Res. 23:3461–3473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hawsawi O, Henderson V, Burton LJ, Dougan
J, Nagappan P and Odero-Marah V: High mobility group A2 (HMGA2)
promotes EMT via MAPK pathway in prostate cancer. Biochem Biophys
Res Commun. 504:196–202. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ping H, Guo L, Xi J and Wang D:
Angiotensin II type 2 receptor-interacting protein 3a inhibits
ovarian carcinoma metastasis via the extracellular HMGA2-mediated
ERK/EMT pathway. Tumour Biol. 39:10104283177133892017.PubMed/NCBI
|
|
57
|
Kao CY, Yang PM, Wu MH, Huang CC, Lee YC
and Lee KH: Heat shock protein 90 is involved in the regulation of
HMGA2-driven growth and epithelial-to-mesenchymal transition of
colorectal cancer cells. PeerJ. 4:e16832016. View Article : Google Scholar : PubMed/NCBI
|
